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The semi-synthetic sulfated polysaccharide PPS (pentosan
polysulfate) increases afﬁnity between the aggrecan-degrading
ADAMTSs (adamalysins with thrombospondin motifs) and
their endogenous inhibitor, TIMP (tissue inhibitor of metallo-
proteinases)-3. In the present study we demonstrate that PPS
mediates the formation of a high-afﬁnity trimolecular complex
with ADAMTS-5 and TIMP-3. A TIMP-3 mutant that lacks
extracellular-matrix-bindingabilitywasinsensitivetothisafﬁnity
increase, and truncated forms of ADAMTS-5 that lack the Sp
(spacer) domain had reduced PPS-binding ability and sensitivity
to the afﬁnity increase. PPS molecules composed of 11 or more
saccharide units were 100-fold more effective than those of
eight saccharide units, indicating the involvement of extended or
multipleprotein-interactionsites.Theformationofahigh-afﬁnity
trimolecularcomplexwascompletelyabolishedinthepresenceof
0.4 M NaCl. These results suggest that PPS enhances the afﬁnity
between ADAMTS-5 and TIMP-3 by forming electrostatically
driven trimolecular complexes under physiological conditions.
Key words: adamalysin with thrombospondin motifs 5
(ADAMTS-5), aggrecanase, extracellular matrix, glycosamino-
glycan, osteoarthritis, tissue inhibitor of metalloproteinases 3
(TIMP-3).
INTRODUCTION
ADAMTS-5 [adamalysin with TS (thrombospondin) motifs 5]
is considered to play a key role in the development of OA
(osteoarthritis) through its degradation of aggrecan, the major
proteoglycan component of the cartilage extracellular matrix
[1,2]. As there are currently no disease-modifying therapeutics
available to treat OA, there has been considerable interest in
developing ADAMTS-5 inhibitors to block aggrecan degradation
in cartilage. Synthetic ADAMTS-5 inhibitors [3,4], as well as
the endogenous ADAMTS inhibitor TIMP (tissue inhibitor of
metalloproteinases)-3 [5], are able to block aggrecan degradation
in cartilage explants.
In an alternative approach, we have demonstrated that PPS
(pentosan polysulfate), a semi-synthetic molecule manufactured
from beechwood hemicellulose by sulfate esteriﬁcation of
the xylopyranose hydroxy groups, is able to block aggrecan
degradation by shifting the balance between ADAMTS-5 and
TIMP-3 in the cartilage by blocking LRP [LDL (low-density
lipoprotein) receptor-related protein]-mediated endocytosis of
TIMP-3bychondrocytes[6].PPSisalsoabletodirectlyinhibitthe
aggrecanolytic activity of ADAMTS-5 and, more importantly, it
increases the afﬁnity between ADAMTS-5 and TIMP-3,allowing
lower concentrations of TIMP-3 to effectively inhibit ADAMTS-
5 [6]. This is of particular importance given that TIMP-3 levels
are reduced in OA cartilage [7].
In the present study we investigated the molecular mechanism
by which PPS increases the afﬁnity between ADAMTS-5 and
TIMP-3, since elucidation of the mechanism of action and of
the structural determinants required for PPS activity will
enable development of novel chondroprotective agents able
to increase the ADAMTS–TIMP-3 afﬁnity with an improved
pharmacokinetic proﬁle. Kinetic analysis of the ADAMTS-
5–TIMP-3 interaction has become more amenable since the
development of ﬂuorescent peptide substrates for the enzyme
[8,9].WeusedsuchasubstratetodeﬁnetheregionsofADAMTS-
5 and TIMP-3, as well as the minimal size of PPS required for the
afﬁnity increase. We have found that forms of ADAMTS-5 and
TIMP-3 with reduced ability to bind to PPS were less susceptible
totheafﬁnityincrease,anddemonstratethattheincreaseinafﬁnity
involves the reversible formation of an electrostatically driven
trimolecular complex.
MATERIALS AND METHODS
Materials
Sodium PPS was from Bene-PharmaChemie. Recombinant
human TIMP-3, N-TIMP-3 (N-terminal domain of TIMP-3) and
ADAMTS-5(full-lengthandtruncatedforms)werepreparedwith
a C-terminal FLAG tag, as described previously [9,10]. TIMP-
1, MMP (matrix metalloproteinase)-1 catalytic domain, MMP-2
and MMP-3 catalytic domain were prepared as described
previously[9].TIMPswerequantiﬁedbytitrationagainstaknown
concentrationofthecatalyticdomainofMMP-3,andADAMTS-5
andMMPswerequantiﬁedbytitrationagainstaknownconcentra-
tion of N-TIMP-3 and TIMP-1 respectively. Porcine heparin, M2
anti-FLAGchromatographyresinandantibodywerefromSigma–
Aldrich. Streptavidin–Sepharose was from GE Healthcare.
Abbreviations used: ADAMTS, adamalysin with thrombospondin motifs; ATIII, antithrombin III; CysR, cysteine-rich; Dis, disintegrin; DMEM, Dulbecco’s
modiﬁed Eagle’s medium; dp, degree of polymerization; HEK, human embryonic kidney; MMP, matrix metalloproteinase; OA, osteoarthritis; PPS, pentosan
polysulfate; Bio-PPS, biotinylated PPS; Sp, spacer; TBA, tetrabutyl ammonium; TIMP, tissue inhibitor of metalloproteinases; N-TIMP-3, N-terminal domain
of TIMP-3; TS, thrombospondin.
1 To whom correspondence should be addressed (email linda.troeberg@kennedy.ox.ac.uk).
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Fluorescent substrate assays
The activity of ADAMTS-5 was monitored using the
ﬂuorescent peptide substrate o-aminobenzoyl-Thr-Glu-Ser-
Glu∼Ser-Arg-Gly-Ala-Ile-Tyr-(N-3-[2,4-dinitrophenyl]-L-2,3-di-
aminopropionyl)-Lys-Lys-NH2 [Abz-TESE∼SRGAIY-Dpa-KK]
(custom synthesized by Bachem) at a ﬁnal concentration of
20 μM with an excitation wavelength of 300 nm and an emission
wavelength of 430 nm (420 nm cut-off) [9]. All assays were
conducted at 37◦C in TNC buffer [50 mM Tris/HCl, 150 mM
NaCl, 10 mM CaCl2,0 . 0 5% Brij-35 and 0.02% sodium azide).
This buffer was prepared with a pH of 7.70 at 20◦C, giving a pH
of 7.30 at 37◦C.
Assays were conducted in sealed 0.5 ml microfuge tubes
with endpoint ﬂuorescence measured after 18 h using a Gemini
microplate spectroﬂuorometer (Molecular Devices). A series of
triplicate endpoint measurements conﬁrmed that the increase in
ﬂuorescence was linear over the 18 h assay period, and that
ADAMTS-5 and TIMP-3 remained stable over 18 h under these
assayconditions.PPSconcentrationsofupto10 μMhadnoeffect
on ADAMTS-5 hydrolysis of the synthetic substrate.
The MMP-1 catalytic domain, MMP-2 and MMP-3 catalytic
domain were assayed as described previously [9].
Measurement of the inhibition constant Ki
Ki values were determined under steady-state kinetic conditions
[9,11]. Various forms of ADAMTS-5 (0.5 nM), MMP-1 catalytic
domain (1 nM), MMP-2 (0.02 nM) or MMP-3 catalytic domain
(1 nM) were incubated with TIMP-3 (0.1–10 nM) in the presence
of various concentrations of PPS for 1 h at 37◦C. Steady-state
rates of substrate hydrolysis (vs) were then determined (18 h,
37◦C). The tight-binding equation [11] (eqn 1) was ﬁtted to the
data using Prism software (GraphPad).
vs
vo
= 1 −
Eo+Io + Ki(app) −

(Eo+Io + Ki(app))
2 − 4EoKi(app)
 1
2
2Eo
(1)
where vo is steady-state rate of substrate hydrolysis in the absence
of TIMP-3, Eo is the total enzyme concentration, Io is the
total inhibitor concentration and Ki(app) is the apparent inhibition
constant. Ki was calculated by dividing Ki(app) by a (1+[S]/Km)
value of 1.26 [9], assuming a linear competitive mechanism for
inhibition of ADAMTS-5 by TIMP-3 in the presence of PPS.
Biotinylation of PPS
Sodium PPS (100 mg) was converted into the TBA (tetrabutyl
ammonium) salt by incubating with TBA bromide (100 mg)
(Sigma–Aldrich) dissolved in 10 ml of de-ionized water for 4 h at
ambient temperature. PPS-TBA was dialysed against de-ionized
water for 24 h to remove salt and freeze-dried. PPS-TBA (50 mg,
dissolved in 1 ml of DMSO) was mixed with 1,1-carbonyl di-
imidazole (28 mg in 0.5 ml of water; Sigma–Aldrich) and heated
at 56◦C for 1 h. Biotin hydrazide (47.8 mg; Sigma–Aldrich) was
added and the solution was incubated with shaking for 16 h at
45◦C. The biotinylated PPS TBA salt was converted into the
sodium salt by addition of excess 4 M NaCl, dialysis against
water andfreeze-drying. Bio-PPS (biotinylated PPS)was puriﬁed
by size-exclusion chromatography on a Superdex-200 column
(GE Healthcare) equilibrated in 0.25 M NaCl. Column fractions
were monitored for PPS using the dimethylmethylene blue assay
[12] and for biotin with the 4
 -hydroxyazobenzene-2-carboxylic
acid/avidin reagent (Sigma–Aldrich). Fractions positive for PPS
and biotin were pooled, desalted and freeze-dried. The purity of
Bio-PPS was established by NMR spectroscopy.
C-terminally truncated forms of ADAMTS-5 (100 nM) and
TIMP-3 (100 nM) were incubated with or without Bio-PPS
(1 μM, calculated using an average molecular mass of 4.7 kDa)
(1 h, 37◦C, 50 μl total volume). In the case of ADAMTS5-
2, the active-site-directed metalloproteinase inhibitor GM6001
(10 μM; Elastin Products Company) was included to prevent
autoproteolysisintheabsenceofTIMP-3.ProteinsboundstoBio-
PPS were recovered by the addition of streptavidin–Sepharose
(30 μlo fa5 0 % slurry equilibrated in TNC buffer for 2 h at
25◦C). After washing the beads (three washes in 200 μlo fT N C
buffer), bound proteins were eluted with reducing SDS sample
buffer (75 μl) and analysed by immunoblotting with an M2 anti-
FLAG antibody (Sigma–Aldrich).
Expression and puriﬁcation of
TIMP-3(K26/27/30/76E+R163/K165Q)
The K26/27/30/76E+R163/K165Q mutant of TIMP-3 [13] was
recombinantlyexpressedinHEK(humanembryonickidney)-293
cells using a pCEP4-based expression vector (Invitrogen). This
vector was created by PCR using the previously described TIMP-
3(K26/27/30/76E+R163/K165Q) expression vector [13] as a
template, with the sense primer 5
 -CTCGAGTCCCTTTTTTT-
TCCACAGGAGCTCGCCGCCACCATGACCCCTTGGCTCG-
GGCTCATCGTGCTC-3
  containing an XhoI site (underlined),
Kozak consensus sequence (in italics) and TIMP-3 N-terminal
sequence, and the antisense primer 5
 -C T C G A G CTAATGGTGA-
TGGTGATGGTGGGGGTCTGTGGCATTGATGATGCTTTTA-
TCCGG-3
  containing an XhoI site (underlined), a His6 tag
(stop-His-His-His-His-His-His) (in italics) and the C-terminal
sequence of TIMP-3. The PCR product was digested with XhoI
andligatedintosimilarlydigestedpCEP4.Cloneswiththecorrect
orientationwereidentiﬁedbyrestrictiondigestionandsequenced.
HEK-293 cells were transiently transfected with the expression
vector using Lipofectamine
TM 2000 (Invitrogen) in DMEM
(Dulbecco’s modiﬁed Eagle’s medium) containing 10% (v/v)
FBS (fetal bovine serum), penicillin (100 units/ml) and
streptomycin (100 units/ml). After 2 days, cells were treated with
serum-free DMEM containing 30 mM sodium chlorate (Sigma–
Aldrich) [9]. Medium was collected after 3 days and centrifuged
to remove cell debris. To reduce the concentration of histidine,
the conditioned medium was concentrated 10-fold in a Vivacell
250 ﬁltration unit (5 kDa cut-off; Sartorius) and then diluted
10-fold in TNC buffer. The medium was applied to a 1 ml
Ni-NTA (Ni
2+-nitrilotriacetate) resin (Qiagen) equilibrated in
TNC buffer and the resin was washed in the same buffer to
removeunboundproteins.Boundproteinwaselutedwith300 mM
imidazole(Sigma–Aldrich)andextensivelydialysedagainstTNC
buffer.
The purity of TIMP-3(K26/27/30/76E+R163/K165Q) was
conﬁrmed by reducing SDS/PAGE [14] and immunoblotting
using a polyclonal rabbit anti-TIMP-3 antibody (Abcam,
catalogue number ab39184). The active concentration of the
proteinwasdeterminedbytitrationagainstaknownconcentration
of the catalytic domain of MMP-1.
Solid-phase binding assays for PPS binding
PPS(2.5 μMinPBS)wascoatedovernightat25◦Contoheparin-
binding plates (BD Life Sciences) [15]. Wells were washed in
TNCbuffercontaining0.1%Tween20(Sigma–Aldrich)between
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each subsequent incubation. Wells were blocked with 0.2%
gelatin in TNC buffer and then incubated with recombinant
ADAMTS-5 or TIMP-3 (0.1–40 nM in blocking solution for
3ha t3 7◦C). Bound proteins were detected using either an M2
anti-FLAG antibody (Sigma–Aldrich) or a rabbit anti-TIMP-3
antibody (Abcam, catalogue number ab39184, for 3 h at 37◦C),
followed by a species-appropriate secondary antibody coupled to
horseradish peroxidase (Dako; for 1 h at 37◦C). Hydrolysis of
tetramethylbenzidine substrate (KPL) was measured at 450 nm
using a BioTek EL-808 absorbance microplate reader.
PPS preparative and analytical size-exclusion chromatography
PPS (40 mg) was applied to Sephadex 30 (GE Healthcare)
equilibrated in water at 0.5 ml/min. Fractions (5 ml) were
evaluated using the Dimethylmethylene Blue (Sigma–Aldrich)
dyeassay[12].TheeluatebetweenVo (15 ml)andVt (105 ml)was
dividedintosixpools(15 mleach),freeze-driedandreconstituted
in a small volume of TNC buffer.
The molecular mass of the parent PPS and preparative
size-exclusion chromatography fractions was determined by
high-performance gel-permeation chromatography [16]. The
chromatographicsystemTSKSWXLG3000andG2000columns
(30 mm×0.7 mm; Anachem) in series with a refractive index
detector, was calibrated using the 1st International Reference
PreparationLowMolecularWeightHeparinforMolecularWeight
Calibration [NIBSC (National Institute for Biological Standards
and Control), Potters Bar, U.K., code 90/686]. The average dp
(degree of polymerization) of the PPS fractions was determined
by dividing their average molecular mass by the molecular mass
of a single pentosan sulfate unit (290 Da).
RESULTS
PPS increases the afﬁnity between TIMP-3 and ADAMTS-5
We have previously shown that PPS increases the afﬁnity
between TIMP-3 and full-length ADAMTS-5 using recombinant
aggrecan interglobular domain as a substrate [6]. We conﬁrmed
this observation using Abz-TESE∼SRGAIY-Dpa-KK, a more
convenientquenchedﬂuorescentpeptidesubstrateforADAMTS-
5. The rate of hydrolysis of Abz-TESE∼SRGAIY-Dpa-KK by
ADAMTS-5 was not directly inhibited by PPS at concentrations
up to 10 μM.
In the absence of PPS, a Ki value of 0.56+ −0.03 nM was de-
termined,inagreementwithpreviousﬁndings[9].Inthepresence
of 25 nM (0.1 μg/ml) PPS, Ki was too low to be determined,
with 0.5 nM ADAMTS-5 completely inhibited by an equimolar
amountofTIMP-3(Figure1A).TheafﬁnityofN-TIMP-3forfull-
length ADAMTS-5 was similarly increased by PPS (Figure 1B).
Accurate determination of the improved Ki values was not
possible, as ADAMTS-5 concentrations below 0.5 nM cannot be
reliably assayed with the currently available substrates. Heparin
also increased the afﬁnity between TIMP-3 and full-length
ADAMTS-5, although 10-fold higher heparin concentrations
were required. Other glycosaminoglycans, such as dermatan
sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate and hyalur-
onic acid had no effect on afﬁnity at concentrations up to 1 μM.
To determine the speciﬁcity of this result, the effect of PPS on
TIMP-3 afﬁnity for other metalloproteinases and on ADAMTS-5
afﬁnity for TIMP-1 was assessed. Ki values of 0.43+ −0.12 nM,
0.16+ −0.002 nMand0.90+ −0.28 nMweredeterminedforTIMP-
3 inhibition of the catalytic domain of MMP-1, MMP-2 and
the catalytic domain of MMP-3 respectively, in agreement with
previous studies [9,17]. The addition of 25 nM PPS had no effect
onTIMP-3afﬁnityfortheseMMPs(Figures1D–1F).PPSslightly
improved the ADAMTS-5 afﬁnity for TIMP-1, with the addition
of 25 nM PPS reducing the Ki value from 734+ −0.16 nM to
522+ −0.24 nM (Figure 1C).
The Sp (spacer) domain of ADAMTS-5 promotes an afﬁnity
increase and PPS binding
The domains of ADAMTS-5 required for binding to PPS and for
the afﬁnity increase were examined using forms of the enzyme
lacking sequential C-terminal non-catalytic domains (Figure 2A).
At concentrations near the Ki of 0.56+ −0.03 nM, ADAMTS-
5 is only partially inhibited by TIMP-3. Thus incubation of
0.5 nM full-length ADAMTS-5 with an equimolar concentration
of TIMP-3 reduced enzyme activity to 80%. PPS increased
the afﬁnity between full-length ADAMTS-5 and TIMP-3, such
that at PPS concentrations above 10 nM, 0.5 nM full-length
ADAMTS-5 (ADAMTS5-1) was completely inhibited by 0.5 nM
TIMP-3 (Figure 2B). Deletion of the C-terminal TS domain
(ADAMTS5-2) had little effect on susceptibility to the afﬁnity
increase, but deletion of the Sp domain (ADAMTS5-3) reduced
PPS effectiveness, with EC50 increasing from 1 nM to 10 nM
(Figure 2B). Further deletion of the CysR (cysteine-rich) domain
(ADAMTS5-4) and ﬁrst TS domain (ADAMTS5-5) had little
additional effect on the afﬁnity increase. The effect of the Dis
(disintegrin)domainofADAMTS-5ontheafﬁnityincreasecould
notbeassessedasthecatalyticdomainalonehasminimalcatalytic
activity against the synthetic substrate used.
A solid-phase binding assay was used to evaluate whether the
afﬁnity increase correlated with direct binding to PPS. PPS was
coated on to multi-well plates [15] and subsequent binding of
various forms of ADAMTS-5 was quantiﬁed using an antibody
againsttheirC-terminalFLAGtag.ADAMTS5-2,lackingtheTS-
2domain,boundstronglytoimmobilizedPPS.Bindingwasmuch
reducedbydeletionoftheSpdomain(ADAMTS5-3)(Figure2C),
whereas further deletion of the CysR domain (ADAMTS5-4) had
little effect. Binding was further reduced by deletion of the TS-1
domain, with binding of ADAMTS5-5 detectable only at high
concentrations.
TIMP-3 binding to PPS is required for the afﬁnity increase
ATIMP-3mutantwithlowPPS-bindingabilitywasusedtoassess
whethertheafﬁnityincreaserequiresTIMP-3bindingtoPPS.Lee
et al. [13] mutated several positively charged residues of TIMP-
3 to generate TIMP-3(K26/27/30/76E+R163/K165Q), which
was unable to bind to the extracellular matrix. We postulated
that this mutant would also exhibit reduced binding to PPS.
We recombinantly expressed and puriﬁed the mutant with a
C-terminal His6 tag (Figure 3A), and conﬁrmed it to be an
effective ADAMTS inhibitor, with a Ki value of 1.34+ −0.04 nM
for ADAMTS5-2, comparable with that of wild-type TIMP-3.
Binding of TIMP-3(K26/27/30/76E+R163/K165Q) to PPS
was evaluated using a solid-phase binding assay as described
above. Binding of TIMP-3 and TIMP-3(K26/27/30/76E+R163/
K165Q) was quantiﬁed using a polyclonal rabbit anti-TIMP-
3 antibody which reacts comparably with both proteins
(Figure 3A). TIMP-3 bound strongly to the immobilized PPS,
whereas TIMP-3(K26/27/30/76E+R163/K165Q) bound only
weakly to immobilized PPS (Figure 3C).
Addition of PPS (10 nM) had no effect on the TIMP-
3(K26/27/30/76E+R163/K165Q) afﬁnity for ADAMTS5-2
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Figure 1 PPS improves the afﬁnity between full-length ADAMTS-5 and TIMP-3
Enzymes were incubated with TIMP-3 in the absence () or presence () of 25nM PPS (for 1 h at 37◦C) and residual activity was determined. (A) TIMP-3 (0.5–5nM) inhibition of full-length
ADAMTS-5 (0.5nM). (B) N-TIMP-3 (0.5–5nM) inhibition of full-length ADAMTS-5 (0.5nM). (C) TIMP-1 (50–1000nM) inhibition of ADAMTS-5 (0.5nM). (D) TIMP-3 (0.4–25nM) inhibition of
MMP-1 catalytic domain(1 nM).(E) TIMP-3 (0.1–1nM) inhibition ofMMP-2 (0.02nM). (F) TIMP-3 (0.4–25nM) inhibition of MMP-3 catalytic domain (1nM).Continuouslinesrepresentthebest
ﬁt obtained by non-linear regression analysis of the data using eqn (1).
Figure 2 The Sp domain of ADAMTS-5 promotes PPS binding and an afﬁnity increase
(A) Schematic representation of ADAMTS-5 forms lacking sequential C-terminal domains. (B) Effect of PPS on the afﬁnity between TIMP-3 and different forms of ADAMTS-5. TIMP-3 (0.5nM) and
ADAMTS-5forms(0.5 nM,symbolsasshowninA)wereincubatedwithPPS(0.5–1000nMfor1 hat37◦C)andresidualactivityagainstAbz-TESE∼SRGAIY-Dpa-KKwasdetermined(18h,37◦C).
(C) PPS (2.5μM) was immobilized on glycosaminoglyan-binding multi-well plates and wells were then incubated with various forms of ADAMTS-5 (0.4–25nM, symbols as shown in A). Bound
ADAMTS-5 was detected using an M2 anti-FLAG antibody.
Figure 3 Binding of TIMP-3 to PPS is a prerequisite for the afﬁnity increase
(A)ImmunoblotshowingthecomparablereactivityofrecombinantTIMP-3(lane1,10ng)andTIMP-3(K26/27/30/76E+R163/K165Q)(lane2,10ng)withapolyclonalrabbitanti-TIMP-3antibody.
ThemolecularmassinkDaisindicated.(B)TIMP-3(K26/27/30/76E+R163/K165Q)(0.5–10nM)wasincubatedwithADAMTS5-2(0.5nM)intheabsence()orinthepresence()of25nMPPS
(1 h, 37◦C), and residual activity against Abz-TESE∼SRGAIY-Dpa-KK was determined (18h, 37◦C). Continuous and broken lines represent the best ﬁt obtained by non-linear regression analysis
of the data using eqn (1). (C) PPS (2.5μM) was immobilized on glycosaminoglyan-binding multi-well plates and subsequent binding of TIMP-3 () or TIMP-3(K26/27/30/76E+R163/K165Q)
() (0.3–40nM) was detected using a polyclonal rabbit anti-TIMP-3 antibody.
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Table 1 Fractions from analytical size-exclusion chromatography
Fraction Molecular mass (kDa) Polydispersity Average dp
Parent PPS 4.7 1.591 16
F1 10.3 1.139 35
F2 7.3 1.139 25
F3 4.8 1.088 16
F4 3.3 1.048 11
F5 2.4 1.221 8.4
F6 2.4 1.216 8.2
(Figure 3B), indicating that TIMP-3 binding to PPS is a pre-
requisite for the afﬁnity increase.
Longer PPS molecules are more effective
Our preparation of PPS was eluted as a broad peak on analytical
size-exclusion chromatography, indicating that it was made
up of heterogeneously sized PPS molecules. We fractionated
the preparation on a preparative size-exclusion chromatography
Sephadex 30 resin and divided the eluate into six fractions,
designated F1–F6. The average molecular masses and dp of
the fractions were determined by analytical size-exclusion
chromatography and ranged between 10.3 kDa (dp 35) and
2.4 kDa (dp 8) (Table 1).
F1 (10.3 kDa, dp 35), F2 (7.3 kDa, dp 25), F3 (4.8 kDa, dp 16)
andF4(3.3 kDa,dp11)wereequallyabletoincreaseADAMTS5-
2–TIMP-3 afﬁnity (Figure 4A), with concentrations above 10 nM
enabling complete inhibition of 0.5 nM ADAMTS5-2 by
0.5 nM TIMP-3. F5 (2.4 kDa, dp 8) and F6 (2.4 kDa, dp 8)
were less active, with 100-fold higher concentrations of these
fractions required for a comparable increase in ADAMTS5-2–
TIMP-3 afﬁnity.
The ability of the various PPS fractions to bind to TIMP-3
and ADAMTS5-2 was determined by solid-phase binding assays.
Both TIMP-3 (Figure 4B) and ADAMTS5-2 (Figure 4C) bound
strongly to F1, F2, F3 and F4, and bound weakly to F5 and F6.
PPS F5 is equally effective with ADAMTS5-2 and ADAMTS5-5
Theabilityofshort(F5)andlong(F1)PPSfractionstoincreasethe
ADAMTS5-2–TIMP-3 and ADAMTS5-5–TIMP-3 afﬁnity was
compared. F5 was equally active at increasing afﬁnity between
TIMP-3 and both forms of the enzyme, whereas F1 was more
effective at increasing TIMP-3 afﬁnity for ADAMTS5-2 than for
ADAMTS5-5 (Figure 5A).
Formation of trimolecular PPS–ADAMTS-5–TIMP-3 complexes
We next investigated whether the afﬁnity increase involved
formation of a stable trimolecular complex using Bio-PPS, which
we conﬁrmed was able to increase the ADAMTS-5–TIMP-3
afﬁnity as effectively as unbiotinylated PPS.
TIMP-3 was unable to bind to streptavidin–Sepharose beads,
but when incubated with Bio-PPS, TIMP-3 was retained on the
beads(Figure5B),conﬁrmingthatTIMP-3interactsdirectlywith
PPS. Similarly, ADAMTS5-2 bound to streptavidin–Sepharose
beads in the presence of Bio-PPS (Figure 5B). Complexes
of ADAMTS5-2 and TIMP-3 formed in the presence of Bio-
PPS also bound to streptavidin–Sepharose beads (Figure 5B),
indicating that PPS remains associated with the high-afﬁnity
ADAMTS5-2–TIMP-3 complex, and does not dissociate after
complex formation.
ADAMTS5-5 was not retained on streptavidin–Sepharose
beads after incubation with Bio-PPS (Figure 5B), conﬁrming that
it has low afﬁnity for PPS as shown in the solid-phase binding
assay (Figure 2C). Even upon incubation with TIMP-3, only
a small portion of ADAMTS5-5 was retained on streptavidin–
Sepharose beads, indicating that PPS–ADAMTS5-5–TIMP-3
complexes are of lower afﬁnity than PPS–ADAMTS5-2–
TIMP-3 complexes and dissociate upon washing.
PPS remains effective at high concentrations
PPS may increase the ADAMTS5-2–TIMP-3 afﬁnity by a
bridging mechanism, in which its binding to both proteins
increases the likelihood of their interaction with each other. If so,
then PPS should be less effective at high concentrations, where
each of the two proteins is more likely to bind to separate PPS
molecules. However, even at a concentration of 50 μM, PPS was
able to increase ADAMTS5-2–TIMP-3 afﬁnity to the extent that
0.5 nMADAMTS5-2wascompletelyinhibitedby0.5 nMTIMP-
3 (Figure 5C). PPS thus retained activity at a 100000-fold molar
excess over ADAMTS-5 and TIMP-3.
PPS effect is electrostatic
The effect of ionic strength on the PPS-mediated increase in
ADAMTS-5–TIMP-3 afﬁnity was investigated.
First,theeffectofNaClontheinteractionbetweenTIMP-3and
ADAMTS-5 was analysed. Inhibition of ADAMTS5-2 (0.5 nM)
by TIMP-3 (0.5 nM) was slightly reduced at NaCl concentrations
above 250 mM (Figure 6A, broken line), indicating that there is
an electrostatic element to the interaction of these two proteins.
In contrast, the inhibition of ADAMTS5-5 by TIMP-3 was not
Figure 4 Longer PPS molecules are more effective than short PPS molecules at improving afﬁnity
(A)TIMP-3(0.5 nM)wasincubatedwithADAMTS5-2(0.5nM)andvariousconcentrationsofPPSfractionsF1–F6(seeTable1)for1hat37◦C.TheresidualactivityagainstAbz-TESE∼SRGAIY-Dpa-KK
wasmeasured.(B)PPSfractionsF1–F6(2.5μM)wereimmobilizedonglycosaminoglyan-bindingmulti-wellplatesandwellswerethenincubatedwithTIMP-3.BoundTIMP-3wasquantiﬁedusing
an M2 anti-FLAG antibody. TIMP-3 bound strongly to F1 (,3 5d p ) ,F 2( , 25 dp), F3 (, 16 dp) and F4 (×, 11 dp), but only weakly to F5 (, 8 dp) and F6 (, 8 dp). (C) PPS fractions F1–F6
(2.5 μM) were immobilized on glycosaminoglyan-binding multi-well plates and wells were then incubated with ADAMTS5-2. Bound ADAMTS5-2 was quantiﬁed using an M2 anti-FLAG antibody.
ADAMTS5-2 bound strongly to F1 (), F2 (), F3 () and F4 (×), and weakly to F5 () and F6 ().
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Figure 5 PPS increases afﬁnity by a dual mechanism
(A) TIMP-3 (0.5 nM) was incubated with either ADAMTS5-2 or ADAMTS5-5 (0.5 nM) in the
presence of PPS size-exclusion chromatography fractions F1 or F5 (0.5–1000nM, 1h, 37◦C)
and residual activity against Abz-TESE∼SRGAIY-Dpa-KK was determined (18h, 37◦C). (B)
TIMP-3 (100nM) was incubated with ADAMTS5-2 or ADAMTS-5-5 (100nM) with or without
Bio-PPS (1μM) (1h, 37◦C). Streptavidin–Sepharose beads were added and bound proteins
were recovered in SDS buffer and analysed by immunoblotting with an M2 anti-FLAG antibody.
The molecular mass in kDa is indicated. (C) ADAMTS5-2 (0.5nM) was incubated with TIMP-3
(0.5 nM) in the presence of PPS (0.05nM–50μM) (1h, 37◦C) and residual activity against
Abz-TESE∼SRGAIY-Dpa-KK was determined (18h, 37◦C).
affected by NaCl concentrations of up to 500 mM (Figure 6B,
broken line), indicating that electrostatic interactions do not play
asigniﬁcantroleintheinteractionoftheTIMP-3withthecatalytic
and Dis domain of ADAMTS-5.
The effect of NaCl on PPS–ADAMTS-5–TIMP-3 trimolecular
complex formation was then evaluated. NaCl concentrations
above 200 mM greatly reduced the effect of PPS on the afﬁnity
between ADAMTS5-2 and TIMP-3 (Figure 6A, continuous line)
and the afﬁnity between ADAMTS5-5 and TIMP-3 (Figure 6B,
continuousline).AtNaClconcentrationsabove400 mM,PPSwas
unable to mediate an increase in afﬁnity, indicating that the PPS
interaction with both ADAMTS-5–TIMP-3 complexes is largely
electrostatic.
Figure 6 The PPS effect is electrostatic
(A) TIMP-3 (0.5nM) was incubated with ADAMTS5-2 (0.5nM) in the absence ()o r
presence () of 10nM PPS and 50–500mM NaCl (1 h, 37◦C), and residual activity against
Abz-TESE∼SRGAIY-Dpa-KKwasdetermined(18h,37◦C).(B)TIMP-3(0.5nM)wasincubated
withADAMTS5-5(0.5 nM)intheabsence()orpresence()of100nMPPSand50–500mM
NaCl (1h, 37◦C), and residual activity against Abz-TESE∼SRGAIY-Dpa-KK was determined
(18h, 37◦C). (C) TIMP-3 (0.5nM) was incubated with ADAMTS5-2 (0.5nM) and PPS
(10nM) in TNC buffer (containing 250mM NaCl) at 37◦C for times ranging between 1 and
72h. The concentration of NaCl was then increased to 400mM and residual activity against
Abz-TESE∼SRGAIY-Dpa-KK was determined (18h, 37◦C).
To investigate whether the effect of PPS on afﬁnity was
reversible, we compared the effect of adding NaCl before or after
formation of the ternary PPS–ADAMTS-5–TIMP-3 complex.
When 400 mM NaCl was included during the incubation of
0.5 nM ADAMTS5-2, 0.5 nM TIMP-3 and 10 nM PPS, enhanced
afﬁnity of the enzyme–inhibitor complex was not observed
(Figure 6C). Similarly, when the salt was added after the
PPS–ADAMTS-5–TIMP-3 complex had formed, the enzyme–
inhibitor afﬁnity was reduced to that observed in the absence
of PPS. A similar reduction in afﬁnity was observed when
NaCl was added after 1, 24, 48 or 72 h of complex formation.
This indicates that formation of the higher-afﬁnity complex is
reversible by dissociation of PPS from the complex in high-salt
concentrations.
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DISCUSSION
Using Escherichia coli-expressed recombinant aggrecan
interglobular domain as a substrate, we have previously shown
that the semi-synthetic sulfated molecule PPS is able to increase
the afﬁnity between TIMP-3 and ADAMTS-5 [6]. At the
concentrations used in that study, PPS had no effect on TIMP-3
afﬁnityforMMPsandonlyslightlyincreasedADAMTS-5afﬁnity
for TIMP-1, suggesting that PPS uniquely affects the TIMP-3–
ADAMTS interaction. Therefore we have further investigated the
mechanism of this afﬁnity increase in more detail, and found
that the increase in afﬁnity is associated with the formation of a
trimolecular PPS–ADAMTS-5–TIMP-3 complex. This rules out
the possibility that PPS interacts transiently with the proteins to
increase their afﬁnity and then dissociates, as has been shown
for the heparin-mediated increase in VEGF (vascular endothelial
growth factor)–ﬁbronectin afﬁnity [18]. Furthermore, analysis of
truncatedandmutantformsofADAMTS-5andTIMP-3indicated
that sensitivity to the afﬁnity increase correlates with the ability
of both of the proteins to bind to PPS.
The TIMP-3(K26/27/30/76E+R163/K165Q) mutant does not
bind to the extracellular matrix [13] and it also has greatly
reduced ability to bind to PPS compared with wild-type
TIMP-3 (Figure 3C). This mutant is an effective inhibitor of
ADAMTS-5, but its afﬁnity for the enzyme was not enhanced
by PPS, indicating that binding of TIMP-3 to PPS is a
prerequisite for the afﬁnity increase. The mutated amino acids
in TIMP-3(K26/27/30/76E+R163/K165Q) form a stretch of
basic residues on the surface of the modelled three-dimensional
structure of full-length TIMP-3 [13]. This stretch of residues
lies on the opposite face of the molecule to the reactive ridge
that interacts with metalloproteinases, and extends across both
the N- and the C-terminal TIMP-3 domains [13]. We found
that the N-TIMP-3 afﬁnity for ADAMTS-5 was increased by
PPS, indistinguishably from full-length TIMP-3 (Figure 1B),
indicating that the N-terminal domain contains the minimal
residuesnecessaryforhigh-afﬁnitycomplexformation.However,
while N-TIMP-3 has been shown to bind to heparin–Sepharose
[19], N-TIMP-3 binding to immobilized heparin or PPS was not
detectable in solid-phase binding assays (L. Troeberg and H.
Nagase,unpublishedwork),indicatingthattheC-terminaldomain
ofTIMP-3increasestheafﬁnityforsulfatedglycosaminoglycans,
as argued by Lee et al. [13].
Similarly, truncated forms of ADAMTS-5 with reduced PPS
binding ability showed decreased sensitivity to the PPS-mediated
afﬁnity increase. Deletion of the C-terminal TS-2 domain has no
detectable effect on matrix binding or aggrecanolytic activity of
ADAMTS-5 [10], and had little or no effect on PPS susceptibility
(Figure2B).TheSpdomainhaspreviouslybeensuggestedtobind
to glycosaminoglycans, as it promotes aggrecan hydrolysis [10]
andbindingtotheextracellularmatrix[10].Wefoundthatdeletion
of the Sp domain (ADAMTS5-3) markedly reduced both direct
binding to PPS and susceptibility to the PPS-mediated afﬁnity
increase (Figures 2B and 2C). The Sp domain thus contains a
major glycosaminoglycan-binding site of ADAMTS-5 (site B in
Figure7).TheCysRdomainhasbeenshowntopromoteaggrecan
hydrolysis, extracellular matrix binding and susceptibility to
exosite inhibition by PPS [6,10], but we found that deletion
of this domain (ADAMTS5-4) had little effect on binding to
PPS or susceptibility to the PPS-mediated afﬁnity increase. The
TS-1 domain is reported to contribute to aggrecan binding and
hydrolysis by ADAMTS-4 [20], and deletion of this domain in
ADAMTS-5 (ADAMTS5-5) reduced direct binding to PPS, but
had little effect on the afﬁnity increase (Figures 2B and 2C).
Although ADAMTS5-5 bound weakly to PPS, some binding was
still evident at higher concentrations, in agreement with previous
ﬁndingsthatthisformoftheenzymeretainssomeheparin-binding
ability [21]. These data thus indicate that, in addition to the major
glycosaminoglycan-binding site on the Sp domain of ADAMTS-
5, the TS-1 and catalytic/Dis domains contain additional binding
sites (site A in Figure 7). As ADAMTS5-1 and ADAMTS5-2
containallofthesebindingsites,theybindtoPPSwiththehighest
afﬁnity, and thus require low PPS concentrations for trimolecular
complex formation. Truncated forms of ADAMTS-5 that lack the
Sp domain bind to PPS with lower afﬁnity and require 100-fold
higher PPS concentrations for trimolecular complex formation.
Accurate delineation of the PPS-binding regions of ADAMTS-
5andTIMP-3ishamperedbythelackofthree-dimensionalcrystal
structures of both full-length proteins. Electrostatic interactions
underpin many glycosaminoglycan–protein interactions [22,23],
although non-ionic interactions are also important in some
cases, such as interaction of the heparin pentasaccharide with
ATIII (antithrombin III) [24]. Formation of the PPS–ADAMTS-
5–TIMP-3 complex was prevented by NaCl concentrations
above 400 mM (Figure 6), indicating that the complex is
largely electrostatic in nature. On the basis of the analysis
of 49 heparin-binding domains, Cardin and Weintraub [25]
proposed two consensus sequences for protein interaction with
glycosaminoglycans. TIMP-3 contains neither the XBBXBX
nor XBBBXXBX (where B is a basic residue and X is a
hydropathic residue) motif, although it does contain 25 basic
residues. ADAMTS-5 contains 86 basic residues, as well as
an XBBXBX motif (N
739KKSKG
744) in the Sp domain, which
may constitute the glycosaminoglycan-binding residues of this
domain. Nonetheless, it is more likely that the three-dimensional
arrangement of basic residues in ADAMTS-5 andTIMP-3 dictate
their interaction with sulfated polysaccharides. Chondroitin 6-
sulfate has been shown to increase the TIMP-3 afﬁnity for
Figure 7 Modes of PPS binding to ADAMTS-5–TIMP-3 complexes
Short PPS chains increase the afﬁnity between TIMP-3 and ADAMTS5-5 or ADAMTS5-2 by altering their interaction with the charged environment [mode (i)]. Longer PPS chains further increase
afﬁnitythroughan increasein theGibbsfreeenergyofbindingbroughtaboutbylinking thelow-afﬁnitybindingsites onTIMP-3 andADAMTS5-5 [mode(ii)].SuchlongerPPSchainsareevenmore
effective with ADAMTS5-2, as their length enables them to interact with multiple positively charged regions of the enzyme, increasing the afﬁnity of the trimolecular complex [mode (iii)].
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ADAMTS-4 [8], and we found that heparin (100 nM) was
also able to increase the TIMP-3 afﬁnity for ADAMTS-4 and
ADAMTS-5 (L. Troeberg and H. Nagase, unpublished work).
Heparin has previously been reported to increase the TIMP-3
afﬁnity for two other heparin-binding enzymes, namely MMP-2
and ADAMTS-2 [26,27]. However, in these cases, heparin was
showntobeoptimallyeffectiveata100-foldhigherconcentration
than we found to be necessary to increase TIMP-3–ADAMTS-5
and TIMP-3–ADAMTS-4 activity. This suggests that ADAMTS-
4 and ADAMTS-5 are particularly sensitive to such effects,
possibly due to their high afﬁnity for glycosaminoglycans.
LongerPPSchainsweremoreeffectiveatmediatingtheafﬁnity
increasethanshortchains(Figure4A).PPSwithanaveragelength
of at least 11 saccharide units (F4, dp 11, 3.3 kDa) was 100-fold
more effective than PPS of dp 8 (F5 and F6, 2.4 kDa). PPS of
dp 35 (F1) was no more effective than dp11 (F4), indicating that
11 saccharide units is sufﬁcient to support high-afﬁnity complex
formation. This is in line with previous ﬁndings for heparin bind-
ing to proteins, with a minimal length of dp 5–6 required for hep-
arin binding to a single protein, and dp 10–12 being sufﬁcient to
support simultaneous binding of heparin to two proteins [28–30].
Various other examples of glycosaminoglycan-mediated
increases in protein–protein afﬁnity have been characterized.
In particular, the heparin-mediated increase in afﬁnity between
ATIII and serine proteinases of the coagulation cascade has been
extensively studied. Heparin has been found to act in this system
in two ways: (i) by a template or bridging mechanism, in which
simultaneous binding of heparin to ATIII and the target serine
proteinase increases the likelihood of the proteins interacting
with each other [31], and (ii) by a conformational change
mechanism, in which heparin alters the conformation of ATIII
to generate a form of the protein with higher afﬁnity for the target
proteinase [24,32]. It is possible to discriminate between these
two mechanisms of action by examining the dose-dependence of
the glycosaminoglycan activity. If the glycosaminoglycan acts by
aconformationalchangemechanism,thenitwillbeaseffectiveat
highasatlowconcentrations.If,however,theglycosaminoglycan
acts by a template mechanism, then it should become less
effective at high concentrations, where the proteins are more
likely to bind to different glycosaminoglycan molecules. For
example, ATIII association with thrombin is increased by heparin
concentrations of up to 10
−7 M, but if heparin concentrations
are increased to 10
−5 M, heparin efﬁcacy is reduced [33,34].
We found that PPS was as effective at 10
−4 M as it was at
10
−8 M (Figure 5C), which would appear to indicate that it
acts, at least in part, by inducing a conformational change in
one or both of the proteins. However, our kinetic analysis is
limited by the relatively insensitive substrates currently available
to monitor ADAMTS-5 activity, which do not permit accurate
determination of the improved Ki. The substrates used to study
heparin effects on ATIII inhibition of target proteinases permit
measurement of an up to four orders of magnitude increase in
the second-order rate constant [33,34], whereas the available
ADAMTS substrates permit determination of a less than two
orders of magnitude improvement in Ki. It is therefore possible
that we were unable to detect a decrease in PPS efﬁcacy at
high concentrations. For example, our system is not sensitive
enough to discriminate between a 100-fold increase in afﬁnity
at 10 nM PPS and a 10-fold increase in afﬁnity at 10 μM PPS.
Further investigation using techniques such as NMR and atomic
force microscopy is therefore required to see whether PPS alters
the ADAMTS-5 and/or TIMP-3 conformation. Although TIMPs
are compact molecules that display only limited conformational
ﬂexibility, backbone movement of TIMP-1 has been reported
upon binding to MMP-3 [35]. Subtle changes in conformation
may be sufﬁcient to increase TIMP-3 afﬁnity for ADAMTSs.
Alternatively, the ADAMTSs are multidomain enzymes that
are likely to be conformationally ﬂexible [9,36,37]. Allosteric
modulation of various other proteinases by glycosaminoglycans
and sulfated polysaccharides has been described. For example,
binding of glycosaminoglycans to an exosite of cathepsin K
alters the conformation of the enzyme, allosterically increasing
susceptibilitytoinhibitionbysteﬁnA[38].Similarly,co-operative
binding of PPS to human leucocyte elastase has been shown to
modulate its interaction with inhibitors [39].
We found that NaCl concentrations above 250 mM reduced
the TIMP-3 afﬁnity for ADAMTS5-2, but had little effect
on TIMP-3 afﬁnity for ADAMTS5-5. This indicates that
electrostatic interactions contribute to the TIMP-3 interaction
with ADAMTS5-2, but do not play a signiﬁcant role in the
TIMP-3 interaction with the catalytic and disintegrin domains
(ADAMTS5-5). This mirrors the previous ﬁndings of Wayne
et al. [8], who found that 100 mM NaCl reduced the TIMP-3
afﬁnity for full-length and Sp-domain truncated ADAMTS-4, but
had little effect on the TIMP-3 afﬁnity for forms of the enzyme
lacking the CysR domain. Taken together, these data indicate that
electrostatic interactions govern TIMP-3 interactions with the C-
terminal domains of ADAMTS-4 and ADAMTS-5, but that they
are less signiﬁcant in TIMP-3 interactions with the catalytic and
disintegrin domains.
Furthermore, NaCl concentrations above 400 mM abolished
the effect of PPS on ADAMTS-5–TIMP-3 afﬁnity, indicating
that electrostatic interactions underpin formation of the high-
afﬁnity trimolecular complex. Similarly, NaCl reduced the effect
of chondroitin 6-sulfate on ADAMTS-4–TIMP-3 afﬁnity [8].
Thesedataindicatethattheglycosaminoglycan-mediatedincrease
inTIMP-3afﬁnityforADAMTSsisreversible,andthatitisdriven
by electrostatic interactions.
By comparing the effect of long and short chains of PPS on
the afﬁnity of ADAMTS5-2 and ADAMTS5-5 for TIMP-3 (Fig-
ure 5C), we propose three modes of binding for PPS (Figure 7).
Short PPS chains, such as F5 and F6 (dp 8), bind weakly to
TIMP-3andtoADAMTS5-2andADAMTS5-5,andarethusonly
effective at high concentrations [mode (i)]. Longer PPS chains
(F1–F4, dp 11–35) are more effective at improving the afﬁnity
between TIMP-3 and ADAMTS5-5 as they can simultaneously
bindtobothproteins,withtheafﬁnityofthetrimolecularcomplex
beinggreaterthanthesumoftheindividualPPS–proteinafﬁnities
due to the increase in the Gibbs free energy of binding arising
from connection of two low-afﬁnity binding sites [mode (ii)]
[40].TheselongPPSchains(F1–F4)areevenmoreeffectivewith
ADAMTS5-2thantheyarewithADAMTS5-5astheirfavourable
increase in Gibbs energy is further increased by their ability to
bind with higher afﬁnity to both TIMP-3 and to the multiple bind-
ingsitesonADAMTS5-2[mode(iii)].However,theenhancement
of TIMP-3–ADAMTS-5 afﬁnity is reversible, regardless of the
sizeofPPS.TheexactmechanismbywhichPPSbindingincreases
afﬁnity is not clear. We postulate that PPS may either induce a
reversible conformational changes in one or both proteins, or
that binding of short negatively charged PPS molecules alters
the interaction of ADAMTS-5 and TIMP-3 with the surrounding
solvent due to a shift in molecular surface charge distribution.
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